MOG1: A new susceptibility gene for Brugada syndrome

Circulation: Cardiovascular Genetics

Volumn 4, Issue 3, 2011, Pages 261-268

  Kattygnarath, Darouna ^a,b,d   Maugenre, Svetlana ^a,b   Neyroud, Nathalie ^a,b   Balse, Elise ^a,b   Ichai, Carole ^f   Denjoy, Isabelle ^a,b,c   Dilanian, Gilles ^a,b   Martins, Raphaël P ^a,b   Fressart, Véronique ^a,b,d   Berthet, Myriam ^a,b   Schott, Jean Jacques ^a,g   Leenhardt, Antoine ^c   Probst, Vincent ^a,g,h   Marec, Hervé Le ^a,g,h   Hainque, Bernard ^a,d,e   Coulombe, Alain ^a,b   Hatem, Stéphane N ^a,b   Guicheney, Pascale ^a,b  

^a INSERM   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c HÔPITAL LARIBOISIÈRE   (France)

^d PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

^f University Hospital of Nice University of Nice Sophia Antipolis   (France)

^g UNIVERSITÉ DE NANTES   (France)

^h NANTES UNIVERSITY HOSPITAL   (France)

Author keywords

Arrhythmia; Brugada syndrome; MOG1 protein; Protein trafficking; SCN5A protein; Sodium channels; Sudden cardiac death

Indexed keywords

ASPARAGINE; GLUTAMIC ACID; MULTICOPY SUPPRESSOR OF GSP1 PROTEIN; PROTEIN; SODIUM CHANNEL NAV1.5; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRUGADA SYNDROME; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; GENE SEQUENCE; GENETIC SUSCEPTIBILITY; HEART VENTRICLE FIBRILLATION; HUMAN; HUMAN CELL; IDIOPATHIC DISEASE; MICROSCOPY; MISSENSE MUTATION; MUTANT; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SODIUM CURRENT; WILD TYPE;

AMINO ACID SEQUENCE; ANIMALS; BRUGADA SYNDROME; DNA MUTATIONAL ANALYSIS; ELECTROCARDIOGRAPHY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEK293 CELLS; HUMANS; MOLECULAR SEQUENCE DATA; MYOCYTES, CARDIAC; PATCH-CLAMP TECHNIQUES; RAN GTP-BINDING PROTEIN; RATS; RATS, WISTAR; SEQUENCE ALIGNMENT; SODIUM CHANNELS; TRANSFECTION;

EID: 80052726166     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.110.959130     Document Type: Article

References (31)

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol. 1992;20: 1391-1396.
2. Brugada J, Brugada P. Further characterization of the syndrome of right bundle branch block, ST segment elevation, and sudden cardiac death. J Cardiovasc Electrophysiol. 1997;8:325-331. (Pubitemid 27132168)
3. Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H, Wilde A. Brugada syndrome: report of the Second Consensus Conference: Endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation. 2005;111: 659-670.
4. Chen Q, Kirsch GE, Zhang D, Brugada R, Brugada J, Brugada P, Potenza D, Moya A, Borggrefe M, Breithardt G, Ortiz-Lopez R, Wang Z, Antzelevitch C, O'Brien RE, Schulze-Bahr E, Keating MT, Towbin JA, Wang Q. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature. 1998;392:293-296. (Pubitemid 28155103)
5. Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, Wilde AA, Ackerman MJ. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009;6: 1297-1303.
6. Abriel H. Cardiac sodium channel Na(v)1.5 and interacting proteins: physiology and pathophysiology. J Mol Cell Cardiol. 2010;48:2-11.
7. Watanabe H, Koopmann TT, Le Scouarnec S, Yang T, Ingram CR, Schott JJ, Demolombe S, Probst V, Anselme F, Escande D, Wiesfeld AC, Pfeufer A, Kaab S, Wichmann HE, Hasdemir C, Aizawa Y, Wilde AA, Roden DM, Bezzina CR. Sodium channel beta1 subunit mutations associated with Brugada syndrome and cardiac conduction disease in humans. J Clin Invest. 2008;118:2260-2268. (Pubitemid 351872343)
8. Oki M, Nishimoto T. A protein required for nuclear-protein import, Mog1p, directly interacts with GTP-Gsp1p, the Saccharomyces cerevisiae ran homologue. Proc Natl Acad Sci U S A. 1998;95:15388-15393. (Pubitemid 29018708)
9. Marfatia KA, Harreman MT, Fanara P, Vertino PM, Corbett AH. Identification and characterization of the human MOG1 gene. Gene. 2001; 266:45-56. (Pubitemid 32268655)
10. Quimby BB, Dasso M. The small GTPase Ran: interpreting the signs. Curr Opin Cell Biol. 2003;15:338-344. (Pubitemid 36638653)
11. Steggerda SM, Paschal BM. The mammalian Mog1 protein is a guanine nucleotide release factor for Ran. J Biol Chem. 2000;275:23175-23180. (Pubitemid 30646212)
12. Wu L, Yong SL, Fan C, Ni Y, Yoo S, Zhang T, Zhang X, Obejero-Paz CA, Rho HJ, Ke T, Szafranski P, Jones SW, Chen Q, Wang QK. Identification of a new co-factor, MOG1, required for the full function of cardiac sodium channel Nav 1.5. J Biol Chem. 2008;283:6968-6978.
13. Pinet C, Le Grand B, John GW, Coulombe A. Thrombin facilitation of voltage-gated sodium channel activation in human cardiomyocytes: implications for ischemic sodium loading. Circulation. 2002;106: 2098-2103. (Pubitemid 35192816)
14. Abi-Char J, Maguy A, Coulombe A, Balse E, Ratajczak P, Samuel JL, Nattel S, Hatem SN. Membrane cholesterol modulates Kv1.5 potassium channel distribution and function in rat cardiomyocytes. J Physiol. 2007; 582:1205-1217. (Pubitemid 47104349)
15. Hedley PL, Jorgensen P, Schlamowitz S, Moolman-Smook J, Kanters JK, Corfield VA, Christiansen M. The genetic basis of Brugada syndrome: a mutation update. Hum Mutat. 2009;30:1256-1266.
16. Baroudi G, Pouliot V, Denjoy I, Guicheney P, Shrier A, Chahine M. Novel mechanism for Brugada syndrome: defective surface localization of an SCN5A mutant (R1432G). Circ Res. 2001;88:E78-E83.
17. Tan HL, Bezzina CR, Smits JP, Verkerk AO, Wilde AA. Genetic control of sodium channel function. Cardiovasc Res. 2003;57:961-973. (Pubitemid 36324601)
18. London B, Michalec M, Mehdi H, Zhu X, Kerchner L, Sanyal S, Viswanathan PC, Pfahnl AE, Shang LL, Madhusudanan M, Baty CJ, Lagana S, Aleong R, Gutmann R, Ackerman MJ, McNamara DM, Weiss R, Dudley SC Jr. Mutation in glycerol-3-phosphate dehydrogenase 1 like gene (GPD1-l) decreases cardiac Na+ current and causes inherited arrhythmias. Circulation. 2007;116:2260-2268. (Pubitemid 350100331)
19. Antzelevitch C, Pollevick GD, Cordeiro JM, Casis O, Sanguinetti MC, Aizawa Y, Guerchicoff A, Pfeiffer R, Oliva A, Wollnik B, Gelber P, Bonaros EP Jr, Burashnikov E, Wu Y, Sargent JD, Schickel S, Oberheiden R, Bhatia A, Hsu LF, Haissaguerre M, Schimpf R, Borggrefe M, Wolpert C. Loss-of-function mutations in the cardiac calcium channel underlie a new clinical entity characterized by ST-segment elevation, short QT intervals, and sudden cardiac death. Circulation. 2007;115: 442-449. (Pubitemid 46184195)
20. Hu D, Barajas-Martinez H, Burashnikov E, Springer M, Wu Y, Varro A, Pfeiffer R, Koopmann TT, Cordeiro JM, Guerchicoff A, Pollevick GD, Antzelevitch C. A mutation in the beta 3 subunit of the cardiac sodium channel associated with Brugada ECG phenotype. Circ Cardiovasc Genet. 2009;2:270-278.
21. Delpon E, Cordeiro JM, Nunez L, Thomsen PE, Guerchicoff A, Pollevick GD, Wu Y, Kanters JK, Larsen CT, Hofman-Bang J, Burashnikov E, Christiansen M, Antzelevitch C. Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome. Circ Arrhythm Electrophysiol. 2008;1:209-218.
22. Poelzing S, Forleo C, Samodell M, Dudash L, Sorrentino S, Anaclerio M, Troccoli R, Iacoviello M, Romito R, Guida P, Chahine M, Pitzalis M, Deschenes I. SCN5A polymorphism restores trafficking of a Brugada syndrome mutation on a separate gene. Circulation. 2006;114:368-376. (Pubitemid 44264817)
23. Cordeiro JM, Barajas-Martinez H, Hong K, Burashnikov E, Pfeiffer R, Orsino AM, Wu YS, Hu D, Brugada J, Brugada P, Antzelevitch C, Dumaine R, Brugada R. Compound heterozygous mutations P336L and I1660V in the human cardiac sodium channel associated with the Brugada syndrome. Circulation. 2006;114:2026-2033. (Pubitemid 44706878)
24. Pfahnl AE, Viswanathan PC, Weiss R, Shang LL, Sanyal S, Shusterman V, Kornblit C, London B, Dudley SC Jr. A sodium channel pore mutation causing Brugada syndrome. Heart Rhythm. 2007;4:46-53. (Pubitemid 46002625)
25. Valdivia CR, Tester DJ, Rok BA, Porter CB, Munger TM, Jahangir A, Makielski JC, Ackerman MJ. A trafficking defective, Brugada syndromecausing SCN5A mutation rescued by drugs. Cardiovasc Res. 2004;62: 53-62. (Pubitemid 38326811)
26. Steggerda SM, Paschal BM. Regulation of nuclear import and export by the GTPase Ran. Int Rev Cytol. 2002;217:41-91. (Pubitemid 34498930)
27. Mohler PJ, Rivolta I, Napolitano C, LeMaillet G, Lambert S, Priori SG, Bennett V. Nav1.5 E1053K mutation causing Brugada syndrome blocks binding to ankyrin-G and expression of Nav1.5 on the surface of cardiomyocytes. Proc Natl Acad Sci U S A. 2004;101:17533-17538. (Pubitemid 39657438)
28. Lowe JS, Palygin O, Bhasin N, Hund TJ, Boyden PA, Shibata E, Anderson ME, Mohler PJ. Voltage-gated Nav channel targeting in the heart requires an ankyrin-G dependent cellular pathway. J Cell Biol. 2008;180:173-186.
29. Probst V, Kyndt F, Potet F, Trochu JN, Mialet G, Demolombe S, Schott JJ, Baro I, Escande D, Le Marec H. Haploinsufficiency in combination with aging causes SCN5A-linked hereditary Lenegre disease. J Am Coll Cardiol. 2003;41:643-652. (Pubitemid 36223331)
30. Leoni AL, Gavillet B, Rougier JS, Marionneau C, Probst V, Le Scouarnec S, Schott JJ, Demolombe S, Bruneval P, Huang CL, Colledge WH, Grace AA, Le Marec H, Wilde AA, Mohler PJ, Escande D, Abriel H, Charpentier F. Variable Na(v)1.5 protein expression from the wild-type allele correlates with the penetrance of cardiac conduction disease in the SCN5A(+/-) mouse model. PLoS One. 5:e9298.
31. Remme CA, Wilde AA, Bezzina CR. Cardiac sodium channel overlap syndromes: different faces of SCN5A mutations. Trends Cardiovasc Med. 2008;18:78-87. (Pubitemid 351626603)